Colossal Biosciences

AUSTIN, TX · Founded 2021 · CIK 0001964433 · Biotech · Private

Gene-edited woolly mammoth through advanced genetics and synthetic biology

colossal.com →
Grants
—
No SBIR or STTR on record
Sector median 1 award
Raised
$150M
1 Form D · Feb 2023
44 months since last filing
Contracts
—
No federal contracts on record
Patents
40
0 granted · 40 pending
20× sector median 2 patents

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history, newest first
DateEventSourceAmount
Private capital raisedForm D · SEC$150,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3379Polyrizon Ltd.—$7.5M
3380BlossomHill Therapeutics—$246M
3381Shattuck Labs, Inc.—$164M
3382Colossal Biosciences—$150M
3383PepGen Inc.—$127M
3384MouSensor, Inc.——
3385AGEX THERAPEUTICS INC—$19M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Brian BeardDirector · Executive Officer
  • Tom ChiDirector
  • Benjamin LammDirector · Executive Officer

Patents

USPTO · 0 granted of 40
  • Transgenic Animals And Recombinant Host Cells Comprising Specific Gene Variants And Methods Of Creating Sameapplication
  • Three-dimensional Co-culture System For Embryos Cultured In Vitro And Uses Thereofapplication
  • Nicotinamide Adenine Dinucleotide (nad+) Precursors, Nad Pathway Substrates Compositions And Uses Thereofapplication
  • Manipulation Of Zona Pellucida To Facilitate Delivery Of Nucleic Acids For Gene Editing In Embryoapplication
  • Methods And Compositions For Preventing Or Treating Cancerapplication
  • Multi-Genome Editor Construct and Uses Thereofapplication
  • Methods And Compositions For Creating Elephant Induced Pluripotent Stem Cellsapplication
  • Methods And Compositions For Preventing Or Treating Cancerapplication
  • An Apparatus And Method For A Microfluidic Culture Of Non-adherent Pre-implantation Cells, Tissues, Organoids, Or Embryos Under Environmentally Controlled, Highly Customizable Microenvironmentsapplication
  • An Apparatus And Method For Housing And Transporting An Animalapplication
  • Methods Of Generating Rock Hyrax Ipscapplication
  • Methods And Compositions For Creating Elephant Induced Pluripotent Stem Cellsapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.